Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00935623 · ClinicalTrials.gov registry record · Phase 1
Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in Humans
A Phase 1 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00935623 is a Phase 1 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 12 participants.
The verdict
NCT00935623, a Phase 1 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that volunteers can be safely and reproducibly infected with Plasmodium vivax (P. vivax) by the bites of experimentally infected Anopheles dirus (An. dirus) mosquitoes carrying P. vivax sporozoites in their salivary glands.
Interventions
- BIOLOGICAL Malaria Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-04-21 |
| Est. Completion | 2011-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00935623
The ClinicalTrials.gov registry entry for NCT00935623 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Malaria Challenge is the first listed.
NCT00935623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00935623 about?
NCT00935623 is a clinical study titled "Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in Humans". The purpose of this study is to demonstrate that volunteers can be safely and reproducibly infected with Plasmodium vivax (P. vivax) by the bites of experimentally infected Anopheles dirus (An. dirus) mosquitoes carrying P. vivax sporozoites in their salivary glands.
What is the current status of trial NCT00935623?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2009-04-21. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00935623?
The interventions under investigation include: Malaria Challenge (BIOLOGICAL).
Who is sponsoring clinical trial NCT00935623?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.